Author:
Ding Shuang,Guo Yu,Chen Xiaoya,Du Silin,Han Yongliang,Yan Zichun,Zhu Qiyuan,Li Yongmei
Abstract
AbstractThe aim of this study was to investigate the mechanisms underlying demyelination and remyelination with 7.0 T multiparameter magnetic resonance imaging (MRI) in an alternative cuprizone (CPZ) mouse model of multiple sclerosis (MS). Sixty mice were divided into six groups (n = 10, each), and these groups were imaged with 7.0 T multiparameter MRI and treated with an alternative CPZ administration schedule. T2-weighted imaging (T2WI), susceptibility-weighted imaging (SWI), and diffusion tensor imaging (DTI) were used to compare the splenium of the corpus callosum (sCC) among the groups. Prussian blue and Luxol fast blue staining were performed to assess pathology. The correlations of the mean grayscale value (mGSV) of the pathology results and the MRI metrics were analyzed to evaluate the multiparameter MRI results. One-way ANOVA and post hoc comparison showed that the normalized T2WI (T2-nor), fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD) values were significantly different among the six groups, while the mean phase (Φ) value of SWI was not significantly different among the groups. Correlation analysis showed that the correlation between the T2-nor and mGSV was higher than that among the other values. The correlations among the FA, RD, MD, and mGSV remained instructive. In conclusion, ultrahigh-field multiparameter MRI can reflect the pathological changes associated with and the underlying mechanisms of demyelination and remyelination in MS after the successful establishment of an acute CPZ-induced model.
Funder
the Medicine Scientific Key Research Project of Chongqing Municipal Health and Family Planning Commission of China
the Chongqing Basic Research and Frontier Exploration Project of Chongqing Science and Technology Commission
the Medical Scientific Youth Project of Chongqing Municipal Health and Family Planning Commission of China
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Thompson, A. J., Baranzini, S. E., Geurts, J., Hemmer, B. & Ciccarelli, O. Multiple sclerosis. Lancet 391, 1622 (2018).
2. Filippi, M. et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 18, 198 (2019).
3. Kawachi, I. & Lassmann, H. Neurodegeneration in multiple sclerosis and neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 88, 137 (2017).
4. Sormani, M. P. & Pardini, M. Assessing repair in multiple sclerosis: Outcomes for phase II clinical trials. Neurotherapeutics 14, 924 (2017).
5. Correale, J., Gaitan, M. I., Ysrraelit, M. C. & Fiol, M. P. Progressive multiple sclerosis: From pathogenic mechanisms to treatment. Brain 140, 527 (2017).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献